A child sits on a bed surrounded by a bed net intended to prevent mosquito bites that could transmit malaria, Kenya. A new drug regimen developed at UCSF offers children improved protection against the disease.
Study shows that monthly doses of two common anti-malarial drugs for the first few years of life can provide 95 percent protection against the disease.
Francesca Aweeka, PharmD, a faculty member in the School’s Department of Clinical Pharmacy, will co-lead a new five-year, $3.4 million study funded by the National Institutes of Health (NIH) to address one of the world’s most vexing health problems—preventing malaria, especially in the most...
